Profile data is unavailable for this security.
About the company
OptiBiotix Health Plc is a life sciences company. The Company is engaged in the development of microbial strains, compounds, and formulations, which are used as active ingredients and supplements. It is focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. It is also developing its own range of consumer supplements and health products. Its areas of focus include obesity, cardiovascular health, and diabetes. Its products include SlimBiome, CholBiome, SweetBiotix, WellBiome, OptiBiotics and SlimBiome X3. SlimBiome offers a natural, scientifically supported, non-pharmaceutical approach to reducing hunger and cravings. CholBiome contains Lactobacillus plantarum LPLDL as the only active ingredient, focusing on healthy cholesterol maintenance and delivering tangible health benefits. SweetBiotix is a zero or low-calorie, prebiotic, and a smarter alternative to sugar and existing sweeteners.
- Revenue in GBP (TTM)1.15m
- Net income in GBP-191.00k
- Incorporated2006
- Employees5.00
- LocationOptiBiotix Health PLCInnovation CentreInnovation Way, HeslingtonHESLINGTON Y010 5DGUnited KingdomGBR
- Phone+44 20 7933 8780
- Websitehttp://www.optibiotix.com
Peer analysis
| Company | Revenue (TTM) | Net income (TTM) |
|---|---|---|
| Roquefort Therapeutics PLC | 0.00 | -882.45k |
| ValiRx Plc | 49.78k | -1.78m |
| N4 Pharma PLC | 7.07k | -1.07m |
| TheraCryf PLC | 0.00 | -2.01m |
| Ovoca Bio PLC | 0.00 | 65.12k |
| Cizzle Biotechnology Holdings PLC | 0.00 | -1.12m |
| Futura Medical PLC | 7.93m | -6.29m |
| OptiBiotix Health PLC | 1.15m | -191.00k |
| IXICO PLC | 6.53m | -1.65m |
| Genflow Biosciences PLC | 0.00 | -1.80m |
| Solvonis Therapeutics PLC | 0.00 | -2.60m |
| Fusion Antibodies PLC | 1.60m | -1.47m |
| Sareum Holdings Plc | 0.00 | -4.44m |
Institutional shareholders
| Holder | Shares | % Held |
|---|---|---|
| KW Investment Management Ltd.as of 17 Apr 2025 | 10.31m | 9.98% |
| Hargreaves Lansdown Fund Managers Ltd.as of 17 Apr 2025 | 4.79m | 4.64% |
| Alumni Capital Management LLCas of 24 Jun 2025 | 3.04m | 2.94% |
| IG Markets Ltd.as of 17 Apr 2025 | 2.06m | 2.00% |
| HSBC Global Asset Management (UK) Ltd.as of 17 Apr 2025 | 1.70m | 1.65% |
| Rathbones Investment Management Ltd.as of 17 Apr 2025 | 1.28m | 1.23% |
| HSBC Bank Plc (Market-Maker)as of 17 Apr 2025 | 380.00k | 0.37% |
| iDealing.com Ltd.as of 17 Apr 2025 | 377.00k | 0.37% |
| Winterflood Securities Ltd (Market-Maker)as of 17 Apr 2025 | 274.00k | 0.27% |
| Jarvis Investment Management Ltd.as of 17 Apr 2025 | 263.00k | 0.26% |
